Suboptimal health: a new health dimension for translational medicine
Abstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully ch...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/2001-1326-1-28 |
id |
doaj-a0775e5283ea49d98f8afd222b0b4e7f |
---|---|
record_format |
Article |
spelling |
doaj-a0775e5283ea49d98f8afd222b0b4e7f2020-11-25T02:50:37ZengWileyClinical and Translational Medicine2001-13262012-12-0111n/an/a10.1186/2001-1326-1-28Suboptimal health: a new health dimension for translational medicineWei Wang0Yuxiang Yan1School of Medical SciencesEdith Cowan UniversityPerthAustraliaBeijing Municipal Key Laboratory of Clinical Epidemiology and School of Public HealthCapital Medical UniversityBeijingChinaAbstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully characterization of consistent parameters that define the normal population is the basis to individual differences normalization irrelevant to a given disease process. Self claimed normal status may not represent health because asymptomatic subjects may carry chronic diseases or diseases at their early stage such as cancer, diabetes and hypertension. Methods This paper exemplifies the characterization of the suboptimal health status (SHS) which represents a new public health problem in a population with ambiguous health complaints such as general weakness, unexplained medical syndrome and chronic fatigue. We applied clinical informatics approaches and developed a questionnaire for measuring SHS. The validity and reliability of this approach were evaluated in a small pilot study and then in a cross‐sectional study of 3,405 individuals. Results The final questionnaire congregated into a score (SHSQ‐25) which could significantly distinguish among several abnormal conditions. Conclusion SHSQ‐25 could be used as a translational medicine instrument for health measuring in the general population.https://doi.org/10.1186/2001-1326-1-28Suboptimal healthInstrument SHSQ‐25Chronic diseaseTranslational medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei Wang Yuxiang Yan |
spellingShingle |
Wei Wang Yuxiang Yan Suboptimal health: a new health dimension for translational medicine Clinical and Translational Medicine Suboptimal health Instrument SHSQ‐25 Chronic disease Translational medicine |
author_facet |
Wei Wang Yuxiang Yan |
author_sort |
Wei Wang |
title |
Suboptimal health: a new health dimension for translational medicine |
title_short |
Suboptimal health: a new health dimension for translational medicine |
title_full |
Suboptimal health: a new health dimension for translational medicine |
title_fullStr |
Suboptimal health: a new health dimension for translational medicine |
title_full_unstemmed |
Suboptimal health: a new health dimension for translational medicine |
title_sort |
suboptimal health: a new health dimension for translational medicine |
publisher |
Wiley |
series |
Clinical and Translational Medicine |
issn |
2001-1326 |
publishDate |
2012-12-01 |
description |
Abstract Background One critical premise of disease‐related biomarkers is the definition of the counterpart normality. Contrary to pre‐clinical models that can be carefully tailored according to scientific need, heterogeneity and uncontrollability is the essence of humans in health studies. Fully characterization of consistent parameters that define the normal population is the basis to individual differences normalization irrelevant to a given disease process. Self claimed normal status may not represent health because asymptomatic subjects may carry chronic diseases or diseases at their early stage such as cancer, diabetes and hypertension. Methods This paper exemplifies the characterization of the suboptimal health status (SHS) which represents a new public health problem in a population with ambiguous health complaints such as general weakness, unexplained medical syndrome and chronic fatigue. We applied clinical informatics approaches and developed a questionnaire for measuring SHS. The validity and reliability of this approach were evaluated in a small pilot study and then in a cross‐sectional study of 3,405 individuals. Results The final questionnaire congregated into a score (SHSQ‐25) which could significantly distinguish among several abnormal conditions. Conclusion SHSQ‐25 could be used as a translational medicine instrument for health measuring in the general population. |
topic |
Suboptimal health Instrument SHSQ‐25 Chronic disease Translational medicine |
url |
https://doi.org/10.1186/2001-1326-1-28 |
work_keys_str_mv |
AT weiwang suboptimalhealthanewhealthdimensionfortranslationalmedicine AT yuxiangyan suboptimalhealthanewhealthdimensionfortranslationalmedicine |
_version_ |
1724737531004583936 |